Skip to main content
Clinical Trials/NL-OMON33199
NL-OMON33199CompletedNot Applicable

Confirmed wheezing in infancy as basis for molecular fingerprinting in the prediction of asthma. - Dutch Europrevall Asthma study: EuroPA-study

Academisch Medisch Centrum0 sites1,000 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 11 (—)

Inclusion Criteria

  • Age between 0 and 2 years
  • Informed consent from both parents / guardian

Exclusion Criteria

  • Known metabolic, genetic or syndromal disorders
  • Known inflammatory diseases
  • Known underlying respiratory tract disease like congenital airway abnormalities, cystic fibrosis, primary ciliary dyskinesia, brunchopulmonary dysplasia or bronchiectasis.

Investigators

Similar Trials